A molecule nobody thought to explore may unlock a potential therapeutic target for a debilitating connective tissue disorder, according to Western-led research. Western professor Dr. David O'Gorman and PhD student Christina Raykha have ...
Tags: therapeutic target, connective tissue disorder, Dupuytren's disease
Xiaflex (collagenase clostridium histolyticum) has been approved by the U.S. Food and Drug Administration to treat Peyronie's disease, an uncomfortable curvature of the penis. The drug -- first sanctioned three years ago to treat a hand ...
Tags: Xiaflex, collagenase clostridium histolyticum, Peyronie's disease
The first drug treatment for unusual curvature of the penis has been approved by the U.S. Food and Drug Administration, the agency announced Friday. Men with the condition, called Peyronie's disease, have a lump in the penis that causes ...
Tags: curvature of the penis, Peyronie's disease, FDA, men health
Auxilium Pharmaceuticals, a biopharmaceutical company, has obtained an approval from the US Food and Drug Administration (FDA) for Xiaflex (collagenase clostridium histolyticum) for the treatment of Peyronie's disease. The company claims ...
Tags: Peyronie's Disease Drug, Medicine
Auxilium Pharmaceuticals and Actelion Pharmaceuticals Canada have announced Health Canada notice of compliance (approval) for Xiaflex (collagenase clostridium histolyticum or CCH) to treat Dupuytren's contracture in adults with a palpable ...